Life-extending capacity of new cancer drugs varies widely

(Reuters Health) – Drugs recently approved around the world to fight cancer increased patients’ overall survival, but benefits vary depending on the drug, a new study shows.

Researchers looked at the 62 cancer drugs approved in the U.S. and Europe between 2003 and 2013 and found they extended survival by an average of about 3.5 months.

But nearly a third of the drugs lacked evidence to suggest they increased survival when compared to alternative treatments.

Read Full Article Here >>